Tamoxifen: a new risk factor for cerebral sinus thrombosis.
Masjuan
J
J
Department of Neurology, Hospital Ramón y Cajal, Madrid, Spain. jmasjuan@saludalia.com
Pardo
J
J
Callejo
J M
JM
Andrés
M T
MT
Alvarez-Cermeño
J C
JC
D000925:Anticoagulants / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D003221:Confusion / Q000209:etiology; D020847:Estrogen Receptor Modulators / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008408:Mastectomy; D008875:Middle Aged; D012307:Risk Factors; D012851:Sinus Thrombosis, Intracranial / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
D000925:Anticoagulants; D018931:Antineoplastic Agents, Hormonal; D020847:Estrogen Receptor Modulators; D013629:Tamoxifen; D006493:Heparin